Sudden death in patients with hypertrophic cardiomyopathy (HCM) is rarely associated with exercise, according to research presented at ESC Congress 2016 today by Dr. Gherardo Finocchiaro, a cardiologist at St George's University of London, UK. Nearly 80 percent of patients in the study had no symptoms and only one in five had been diagnosed with HCM before their death.
The Mediterranean diet is associated with a reduced risk of death in patients with a history of cardiovascular disease, according to results from the observational Moli-sani study presented at ESC Congress 2016 today.
Automatic external defibrillators fail to save lives when the public does not have basic life support education, according to research presented today at ESC Congress 2016. The study found that public access defibrillation programs are unevenly deployed across France, with an obvious impact on out-of-hospital cardiac arrest survival rate.
The risk of traffic accidents is increased by 50 percent in patients with an implantable cardioverter defibrillator compared to age and gender matched controls, according to a Danish nationwide registry study presented at ESC Congress 2016 today.
Nebivolol prevents anthracycline-induced cardiotoxicity, according to research presented at ESC Congress 2016 today by Professor Mirela Cleopatra Tomescu, a cardiologist at Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.
Heart failure patients have a 2 percent increased risk of dying with each admission to NHS hospitals, according to research presented at ESC Congress 2016 today. The 15-year study in more than 450,000 patients from the ACALM Study Unit, Birmingham, UK, included 13,416 patients with heart failure.
A study in nearly 15,000 heart failure patients has found that up to 80 percent may not be receiving treatment at doses proven to reduce hospitalizations and improve survival. The research presented at ESC Congress 2016 today highlights the need for doctors to ensure patients are treated appropriately so that the high levels of serious illnesses and death associated with heart failure can be reduced.
Heart failure in the elderly is set to triple by 2060, according to new data from the Age, Gene/Environment Susceptibility (AGES) -- Reykjavík study presented at ESC Congress 2016 today.